Coronavirus Disease 19 (COVID-19) Vaccine Effectiveness Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection During Delta-Dominant and Omicron-Dominant Periods in Japan: A Multicenter Prospective Case-control Study (Factors Associated with SARS-CoV-2 Infection and the Effectiveness of COVID-19 Vaccines Study).

Arashiro, Takeshi; Arima, Yuzo; Muraoka, Hirokazu; Sato, Akihiro; Oba, Kunihiro; Uehara, Yuki; Arioka, Hiroko; Yanai, Hideki; Kuramochi, Jin; Ihara, Genei; +16 more... Chubachi, Kumi; Yanagisawa, Naoki; Nagura, Yoshito; Kato, Yasuyuki; Ueda, Akihiro; Numata, Akira; Kato, Hideaki; Ishii, Koji; Ooki, Takao; Oka, Hideaki; Nishida, Yusuke; Stucky, Ashley; Smith, Chris; Hibberd, Martin; Ariyoshi, Koya; Suzuki, Motoi; (2022) Coronavirus Disease 19 (COVID-19) Vaccine Effectiveness Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection During Delta-Dominant and Omicron-Dominant Periods in Japan: A Multicenter Prospective Case-control Study (Factors Associated with SARS-CoV-2 Infection and the Effectiveness of COVID-19 Vaccines Study). Clinical Infectious Diseases, 76 (3). e108-e115. ISSN 1058-4838 DOI: https://doi.org/10.1093/cid/ciac635

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1093/cid/ciac635

Abstract

Item Type Article
Faculty and Department Faculty of Infectious and Tropical Diseases > Dept of Clinical Research
Research Centre Covid-19 Research
PubMed ID 35918782
Elements ID 181836

Share

Download

Filename: Arashiro_etal_2022_COVID-19-vaccine-effectiveness-against.pdf

Licence: Creative Commons: Attribution-Noncommercial-No Derivative Works 4.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar